NCT06064929: A trial that was reported late by HI-Bio, A Biogen Company
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT06064929 |
|---|---|
| Title | An Open Label Phase 1b Study of Felzartamab in Lupus Nephritis |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 1, 2023 |
| Completion date | June 1, 2026 |
| Required reporting date | June 1, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Jan. 1, 2026 |
| Days late | None |